Seeking Alpha

Jefferies still bullish on Opko despite short call

  • Jefferies is out with some commentary on Opko Health (OPK +5.2%) amid controversy surrounding a short thesis advanced by Lakewood Capital (see Lakewood's article on SA here).
  • "In our view, timely achievements of its laid-out milestones and future sales revenues meeting our expectations (albeit significantly lower than its noted market opportunities) would likely provide potential upside to current levels," analyst Eun Yang says.
  • Buy rating reiterated.
  • Price target is $11.50.
From other sites
Comments (4)
  • Qniform
    , contributor
    Comments (3207) | Send Message
    What an annoying site at that embedded link for commentary. I hate those mouse cursor pop-ups...
    18 Dec 2013, 12:23 PM Reply Like
  • phredwelll
    , contributor
    Comments (6) | Send Message
    I think opko shares are being bought by chairman Frost for family rather than for himself. Opko will be at $36.00 by mid 2014.
    18 Dec 2013, 12:44 PM Reply Like
  • Kf919hk
    , contributor
    Comment (1) | Send Message
    What make you the stock would go that high?
    9 Feb 2014, 12:31 PM Reply Like
  • Spuzdude
    , contributor
    Comments (4) | Send Message
    Agree. The Doctor is way ahead of these short sellers.
    18 Dec 2013, 03:34 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs